BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20196499)

  • 1. Nutritional therapy to attenuate inflammation in HD patients: fact or fiction?
    Sharma A; Gadepally P
    Nephrol News Issues; 2010 Jan; 24(1):26-9. PubMed ID: 20196499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation.
    Morena M; Delbosc S; Dupuy AM; Canaud B; Cristol JP
    Hemodial Int; 2005 Jan; 9(1):37-46. PubMed ID: 16191052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
    Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
    J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory syndrome in patients on hemodialysis.
    Jofré R; Rodriguez-Benitez P; López-Gómez JM; Pérez-Garcia R
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S274-80. PubMed ID: 17130274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N; Senécal L; Dupuy AM; Jaussent I; Delcourt C; Leray H; Rafaelsen S; Bosc JY; Maurice F; Canaud B; Cristol JP
    Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
    Ewers B; Riserus U; Marckmann P
    J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malnutrition in hemodialysis patients: what therapy?
    Bossola M; Muscaritoli M; Tazza L; Giungi S; Tortorelli A; Rossi Fanelli F; Luciani G
    Am J Kidney Dis; 2005 Sep; 46(3):371-86. PubMed ID: 16129199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strong connection between malnutrition, inflammation and arteriosclerosis. Improved treatment of renal failure if underlying factors are attacked].
    Efendic E; Lindholm B; Bergström J; Stenvinkel P
    Lakartidningen; 1999 Oct; 96(42):4538-42. PubMed ID: 10575860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
    Himmelfarb J
    Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients].
    de Mutsert R; Krediet RT
    Ned Tijdschr Geneeskd; 2006 Sep; 150(37):2023-7. PubMed ID: 17058458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic inflammation, oxidative stress and effects of erythropoetin in end-stage renal disease patients].
    Lazarević T; Stojimirović B; Poskurica M; Lazarević M; Mitrović N; Stolić R
    Med Pregl; 2007; 60 Suppl 2():109-13. PubMed ID: 18928173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
    Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional therapy in chronic kidney disease.
    Savica V; Santoro D; Ciolino F; Mallamace A; Calvani M; Savica R; Bellinghieri G
    Nutr Clin Care; 2005; 8(2):70-6. PubMed ID: 16013225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Díez JJ; Vázquez A
    J Nephrol; 2002; 15(2):136-43. PubMed ID: 12018629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
    Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.